semaglutide offers New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect Type 2 diabetes: New Ozempic

There's weekly injections, daily injections, and now even a pill

GLP-1 drugs may be prescribed for the following conditions as per American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) 2025 guidelines 11 : Primary glycaemic indication: GLP-1 RAs are recommended for adults with type 2 diabetes who have not reached their individualised A1C targets (typically when A1C is 1.5% above the agreed glycaemic goal) despite lifestyle measures and foundational therapy such as metformin

A Circana research shows that GLP-1 households are making changes to their food and beverage choices, favoring products offering high protein, energy and hydration

When doses are withdrawn use aseptic technique in order to avoid contamination and preserver solution integrity